Plasmid-mediated fluoroquinolone resistance associated with extra-intestinal
Antibiotic resistance
plasmid-mediated quinolone resistances
quinolone resistance determining regions
Journal
The Indian journal of medical research
ISSN: 0971-5916
Titre abrégé: Indian J Med Res
Pays: India
ID NLM: 0374701
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
entrez:
21
6
2019
pubmed:
21
6
2019
medline:
18
12
2019
Statut:
ppublish
Résumé
Infection from fluoroquinolone-resistant extra-intestinal Escherichia coli is a global concern. In this study, isolation and characterization of fluoroquinolone-resistant extra-intestinal E. coli isolates obtained from hospital samples were undertaken to detect plasmid-mediated quinolone resistance (PMQR) genes. Forty three isolates of E. coli obtained from patients with extra-intestinal infections were subjected to antibiogram to detect fluoroquinolone resistance. The mechanism of fluoroquinolone resistance was determined by the detection of PMQR genes and mutations in quinolone resistance determining region (QRDR). Of the 43 isolates, 36 were resistant to nalidixic acid (83.72%) and 28 to ciprofloxacin (65.11%). Eight E. coli isolates showed total resistance to both the antimicrobials without any minimum inhibitory concentration. The detection of PMQR genes with qnr primers showed the presence of qnrA in two, qnrB in six and qnrS in 21 isolates. The gene coding for quinolone efflux pump (qepA) was not detected in any of the isolates tested. The presence of some unexpressed PMQR genes in fluoroquinolone sensitive isolates was also observed. The detection of silent PMQR genes as observed in the present study presents a risk of the transfer of the silent resistance genes to other microorganisms if present in conjugative plasmids, thus posing a therapeutic challenge to the physicians. Hence, frequent monitoring is to be done for all resistance determinants.
Sections du résumé
Background & objectives
Infection from fluoroquinolone-resistant extra-intestinal Escherichia coli is a global concern. In this study, isolation and characterization of fluoroquinolone-resistant extra-intestinal E. coli isolates obtained from hospital samples were undertaken to detect plasmid-mediated quinolone resistance (PMQR) genes.
Methods
Forty three isolates of E. coli obtained from patients with extra-intestinal infections were subjected to antibiogram to detect fluoroquinolone resistance. The mechanism of fluoroquinolone resistance was determined by the detection of PMQR genes and mutations in quinolone resistance determining region (QRDR).
Results
Of the 43 isolates, 36 were resistant to nalidixic acid (83.72%) and 28 to ciprofloxacin (65.11%). Eight E. coli isolates showed total resistance to both the antimicrobials without any minimum inhibitory concentration. The detection of PMQR genes with qnr primers showed the presence of qnrA in two, qnrB in six and qnrS in 21 isolates. The gene coding for quinolone efflux pump (qepA) was not detected in any of the isolates tested. The presence of some unexpressed PMQR genes in fluoroquinolone sensitive isolates was also observed.
Interpretation & conclusions
The detection of silent PMQR genes as observed in the present study presents a risk of the transfer of the silent resistance genes to other microorganisms if present in conjugative plasmids, thus posing a therapeutic challenge to the physicians. Hence, frequent monitoring is to be done for all resistance determinants.
Identifiants
pubmed: 31219083
pii: IndianJMedRes_2019_149_2_192_259589
doi: 10.4103/ijmr.IJMR_2092_17
pmc: PMC6563729
doi:
Substances chimiques
Anti-Bacterial Agents
0
Fluoroquinolones
0
Ciprofloxacin
5E8K9I0O4U
DNA Topoisomerases
EC 5.99.1.-
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
192-198Déclaration de conflit d'intérêts
None
Références
Front Microbiol. 2016 May 23;7:671
pubmed: 27242699
J Vet Diagn Invest. 2008 May;20(3):342-5
pubmed: 18460623
Sci Rep. 2016 Aug 30;6:32281
pubmed: 27573927
Foodborne Pathog Dis. 2010 Feb;7(2):207-15
pubmed: 19911944
Appl Environ Microbiol. 1991 Apr;57(4):1013-7
pubmed: 2059028
J Appl Microbiol. 2012 Jun;112(6):1113-22
pubmed: 22443444
J Antimicrob Chemother. 2005 Sep;56(3):463-9
pubmed: 16020539
J Clin Microbiol. 2013 Jun;51(6):1692-8
pubmed: 23515543
Antimicrob Agents Chemother. 2017 Apr 24;61(5):
pubmed: 28193666
J Clin Lab Anal. 2016 Nov;30(6):947-955
pubmed: 27075845
Am J Med. 2008 Oct;121(10):876-84
pubmed: 18823859
Foodborne Pathog Dis. 2016 Nov;13(11):642-645
pubmed: 27584716
J Antimicrob Chemother. 2002 Mar;49(3):549-52
pubmed: 11864958
Antimicrob Agents Chemother. 2006 Sep;50(9):3003-10
pubmed: 16940095
Antimicrob Agents Chemother. 2010 Aug;54(8):3471-4
pubmed: 20516288
J Antimicrob Chemother. 2011 Jun;66(6):1278-86
pubmed: 21393198
Microb Drug Resist. 2017 Dec;23(8):994-1001
pubmed: 28445079
Sci Rep. 2017 Jan 17;7:40610
pubmed: 28094345
Emerg Infect Dis. 2010 Jan;16(1):88-95
pubmed: 20031048
Can J Infect Dis Med Microbiol. 2014 May;25(3):163-9
pubmed: 25285114
J Appl Microbiol. 2015 Oct;119(4):970-80
pubmed: 26249136
Biomed Res Int. 2014;2014:601630
pubmed: 24860827
Foodborne Pathog Dis. 2007 Winter;4(4):419-31
pubmed: 18041952
Front Microbiol. 2012 Feb 02;3:24
pubmed: 22347217
Antimicrob Agents Chemother. 1998 Oct;42(10):2661-7
pubmed: 9756773
Lancet Infect Dis. 2006 Oct;6(10):629-40
pubmed: 17008172
J Antimicrob Chemother. 2003 May;51 Suppl 1:29-35
pubmed: 12702701
J Antimicrob Chemother. 2013 May;68(5):1025-31
pubmed: 23299573
Antimicrob Agents Chemother. 2009 Apr;53(4):1665-6
pubmed: 19164145
Microb Drug Resist. 2019 Jan/Feb;25(1):23-31
pubmed: 30036132
Gut Pathog. 2016 May 11;8:19
pubmed: 27175218
J Clin Microbiol. 2015 Mar;53(3):766-70
pubmed: 25520451